SCHEMBL4900752

SCHEMBL4900752

CCN(c1ccc(Oc2ccncc2)cc1)S(=O)(=O)c1ccc(C)c(C(=O)OC)c1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
TSHR P16473 1/20 0.44
MMP1 P03956 2/20 0.43
MMP9 P14780 2/20 0.43
MMP13 P45452 2/20 0.43
LMNA P02545 3/20 0.43
MAPT P10636 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ESR1 P03372 2/20 0.42
THRB P10828 1/20 0.42
MCL1 Q07820 1/20 0.41
NPSR1 Q6W5P4 1/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905563 0.90 ALDH1A1 (0.44) ALDH1A1TSHRMMP1MMP9MMP13
SCHEMBL4903818 0.90 ESR1 (0.52) ALDH1A1MMP1MMP9MMP13LMNA
SCHEMBL4907079 0.90 LMNA (0.52) ALDH1A1MMP1MMP9MMP13LMNA
SCHEMBL4902668 0.90 ALDH1A1 (0.46) ALDH1A1TSHRLMNAMAPTSMN1; SMN2
SCHEMBL4903613 0.89 TP53 (0.48) ALDH1A1TSHRMMP1MMP9MMP13
SCHEMBL4906191 0.89 MMP9 (0.41) ALDH1A1TSHRMMP1MMP9MMP13
SCHEMBL4903997 0.89 MAPT (0.49) ALDH1A1TSHRLMNAMAPTSMN1; SMN2
SCHEMBL4895843 0.89 ALDH1A1 (0.50) ALDH1A1TSHRMMP9LMNAMAPT
SCHEMBL4906502 0.88 HDAC8 (0.50) ALDH1A1TSHRMMP9LMNAMAPT
SCHEMBL4904544 0.87 HCRTR2 (0.53) ALDH1A1TSHRLMNAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD ALDH1A1 2664/4885TSHR 412/4885MMP1 4641/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD ALDH1A1 2956/4885TSHR 400/4885MMP1 4581/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD ALDH1A1 2956/4885TSHR 400/4885MMP1 4581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.